Literature DB >> 22932993

Prognostic performance of diffusion-weighted MRI combined with NSE in comatose cardiac arrest survivors treated with mild hypothermia.

Joonghee Kim1, Byung Se Choi, Kyuseok Kim, Cheolkyu Jung, Jae Hyuk Lee, You Hwan Jo, Joong Eui Rhee, Taeyun Kim, Kyeong Won Kang.   

Abstract

BACKGROUND: MRI-based prognostication of comatose cardiac arrest survivors has shown promising results. However, the technique has not been validated in patients treated with therapeutic hypothermia and it is unknown how it might add to NSE-based prognostication. We sought to evaluate the prognostic performance of regional apparent diffusion coefficient (ADC) in comatose out-of-hospital cardiac arrest (OHCA) patients treated with mild hypothermia and its added value to NSE-based prognostication.
METHODS: An OHCA registry was analyzed to identify OHCA patients older than 15 who were treated with therapeutic hypothermia and underwent brain MRI between 2008 and 2011. Quantitative measurement of regional ADCs was performed by a radiologist blinded to the clinical outcome.
RESULTS: Of the 43 eligible patients, 11 (18.6 %) achieved a good outcome (6-month CPC of 1 or 2). The regional ADC of the occipital cortex showed the highest discriminatory power with an area under the curve of receiver operating characteristic (AUROC) of 0.943 (95 % CI, 0.872-1.000) and predicted poor outcomes with a sensitivity of 90.6 % and a specificity of 100 %. The AUROC for NSE levels (48-h) was 0.911 (95 % CI, 0.801-1.000) which was significantly correlated with the regional ADC (Pearson's r = -0.674, p < .001). The ADC-based predictions identified an additional 5 (35.7 %) poor outcome patients out of 14 with 48-h NSE levels less than 78.9 ng/mL, which is the cutoff point suggested in a previous study. However, additional prognostic information was not provided when the 48-h NSE levels were >78.9 ng/mL.
CONCLUSIONS: Regional ADC-based prognostication was accurate in OHCA patients who were treated with mild hypothermia. However, it only provided additional prognostic information when the 48-h NSE levels indicated a good prognosis (48-h NSE <78.9 ng/mL).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22932993     DOI: 10.1007/s12028-012-9773-2

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  16 in total

Review 1.  Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  E F M Wijdicks; A Hijdra; G B Young; C L Bassetti; S Wiebe
Journal:  Neurology       Date:  2006-07-25       Impact factor: 9.910

Review 2.  Neurologic prognosis in cardiac arrest patients treated with therapeutic hypothermia.

Authors:  Nicholas A Blondin; David M Greer
Journal:  Neurologist       Date:  2011-09       Impact factor: 1.398

3.  Predicting neurological outcome in post cardiac arrest patients treated with hypothermia.

Authors:  Jules M Brown; Christopher P Bourdeaux
Journal:  Resuscitation       Date:  2011-03-31       Impact factor: 5.262

4.  Temporal and spatial profile of brain diffusion-weighted MRI after cardiac arrest.

Authors:  Michael Mlynash; Dennis M Campbell; Emily M Leproust; Nancy J Fischbein; Roland Bammer; Irina Eyngorn; Amie W Hsia; Michael Moseley; Christine A C Wijman
Journal:  Stroke       Date:  2010-07-01       Impact factor: 7.914

5.  Sedation confounds outcome prediction in cardiac arrest survivors treated with hypothermia.

Authors:  Edgar A Samaniego; Michael Mlynash; Anna Finley Caulfield; Irina Eyngorn; Christine A C Wijman
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

6.  Prediction of poor outcome within the first 3 days of postanoxic coma.

Authors:  E G J Zandbergen; A Hijdra; J H T M Koelman; A A M Hart; P E Vos; M M Verbeek; R J de Haan
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

7.  Diffusion and perfusion MRI of the brain in comatose patients treated with mild hypothermia after cardiac arrest: a prospective observational study.

Authors:  Hanna Järnum; Linda Knutsson; Malin Rundgren; Roger Siemund; Elisabet Englund; Hans Friberg; Elna-Marie Larsson
Journal:  Resuscitation       Date:  2009-02-10       Impact factor: 5.262

8.  Prognostic value of brain diffusion-weighted imaging after cardiac arrest.

Authors:  Christine A C Wijman; Michael Mlynash; Anna Finley Caulfield; Amie W Hsia; Irina Eyngorn; Roland Bammer; Nancy Fischbein; Gregory W Albers; Michael Moseley
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

9.  Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia.

Authors:  Marjaana Tiainen; Risto O Roine; Ville Pettilä; Olli Takkunen
Journal:  Stroke       Date:  2003-11-20       Impact factor: 7.914

10.  Comatose patients with cardiac arrest: predicting clinical outcome with diffusion-weighted MR imaging.

Authors:  Ona Wu; A Gregory Sorensen; Thomas Benner; Aneesh B Singhal; Karen L Furie; David M Greer
Journal:  Radiology       Date:  2009-05-06       Impact factor: 11.105

View more
  11 in total

Review 1.  Part 8: Post-Cardiac Arrest Care: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Authors:  Clifton W Callaway; Michael W Donnino; Ericka L Fink; Romergryko G Geocadin; Eyal Golan; Karl B Kern; Marion Leary; William J Meurer; Mary Ann Peberdy; Trevonne M Thompson; Janice L Zimmerman
Journal:  Circulation       Date:  2015-11-03       Impact factor: 29.690

Review 2.  Neuroprognostication of hypoxic-ischaemic coma in the therapeutic hypothermia era.

Authors:  David M Greer; Eric S Rosenthal; Ona Wu
Journal:  Nat Rev Neurol       Date:  2014-03-11       Impact factor: 42.937

Review 3.  Neurological prognostication after cardiac arrest.

Authors:  Claudio Sandroni; Romergryko G Geocadin
Journal:  Curr Opin Crit Care       Date:  2015-06       Impact factor: 3.687

Review 4.  How to assess prognosis after cardiac arrest and therapeutic hypothermia.

Authors:  Fabio Taccone; Tobias Cronberg; Hans Friberg; David Greer; Janneke Horn; Mauro Oddo; Sabino Scolletta; Jean-Louis Vincent
Journal:  Crit Care       Date:  2014-01-14       Impact factor: 9.097

5.  Prognostication in comatose survivors of cardiac arrest: an advisory statement from the European Resuscitation Council and the European Society of Intensive Care Medicine.

Authors:  Claudio Sandroni; Alain Cariou; Fabio Cavallaro; Tobias Cronberg; Hans Friberg; Cornelia Hoedemaekers; Janneke Horn; Jerry P Nolan; Andrea O Rossetti; Jasmeet Soar
Journal:  Intensive Care Med       Date:  2014-11-15       Impact factor: 17.440

6.  Imaging for Neuroprognostication After Cardiac Arrest: Systematic Review and Meta-analysis.

Authors:  Neill K J Adhikari; Damon C Scales; Carmen Lopez Soto; Laura Dragoi; Chinthaka C Heyn; Andreas Kramer; Ruxandra Pinto
Journal:  Neurocrit Care       Date:  2020-02       Impact factor: 3.210

7.  Good functional outcome after prolonged postanoxic comatose myoclonic status epilepticus in a patient who had undergone bone marrow transplantation.

Authors:  Jennifer Accardo; Domenico De Lisi; Paola Lazzerini; Alberto Primavera
Journal:  Case Rep Neurol Med       Date:  2013-12-03

8.  Therapeutic hypothermia after cardiac arrest: outcome predictors.

Authors:  Rodrigo Nazário Leão; Paulo Ávila; Raquel Cavaco; Nuno Germano; Luís Bento
Journal:  Rev Bras Ter Intensiva       Date:  2015 Oct-Dec

9.  The risk factors and prognostic implication of acute pulmonary edema in resuscitated cardiac arrest patients.

Authors:  Dae-Hyun Kang; Joonghee Kim; Joong Eui Rhee; Taeyun Kim; Kyuseok Kim; You Hwan Jo; Jin Hee Lee; Jae Hyuk Lee; Yu Jin Kim; Seung Sik Hwang
Journal:  Clin Exp Emerg Med       Date:  2015-06-30

10.  Resuscitation duration inequality by patient characteristics in emergency department out-of-hospital cardiac arrest: an observational study.

Authors:  Minoo Kang; Joonghee Kim; Kyuseok Kim
Journal:  Clin Exp Emerg Med       Date:  2014-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.